研究进展关于对神经退行性疾病的影响
Ziyi Li1, Yanfang Zhao1, Rong Wang2
1Department of Physiology, School of Basic Medical Sciences, Hunan Normal University, Changsha 410013, China.
International journal of molecular sciences
|August 14, 2025
概括
中文土耳其语. 通过减少神经炎症和氧化应激,在神经退行性疾病 (NDD) 中显示出有前途. 它的生物活性化合物为开发新的NDD疗法提供了一种自然的方法.
科学领域:
- 药理学 药理学是指药理学的学科.
- 神经科学是一个神经科学.
- 传统中国医药 传统中国医药
背景情况:
- 中文土耳其语. 是一种传统的中国草药,具有抗炎,抗氧化和神经保护性质.
- 神经退行性疾病 (NDD) 涉及复杂的病理过程,如神经炎症和氧化应激.
研究的目的:
- 审查Thesium chinense土耳其的监管机制. 在NDD中的活性成分.
- 综合其神经保护功效的证据,并评估临床潜力.
主要方法:
- 临床前研究的系统审查.
- 对生物活性成分 (黄,多糖) 的分析.
- 分子目标和途径的阐明.
主要成果:
- 活性成分调节神经炎症和氧化应激路径.
- 在实验性NDD模型中证明了神经保护作用.
- 确定了关键的生物活性化合物及其机制.
结论:
- 中文土耳其语. 对NDDs具有显著的神经保护潜力.
- 提供了基于天然产品的NDD疗法的理论基础.
- 支持NDD管理的进一步临床研究.
更多相关视频
08:27Establishment of a Valuable Mimic of Alzheimer's Disease in Rat Animal Model by Intracerebroventricular Injection of Composited Amyloid Beta Protein
Published on: July 29, 2018
12.1K
05:54Author Spotlight: Exploring Acupuncture in Alzheimer's Research from Thread-Embedding Techniques to Clinical Trials
Published on: May 10, 2024
1.6K
相关概念视频
Alzheimer's Disease: Treatment
261
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
261
Indirect-Acting Cholinergic Agonists: Pharmacological Actions
830
Indirect-acting cholinergic agonists, also known as anticholinesterases, exert their pharmacological effects by enhancing cholinergic transmission in various body parts, including the neuromuscular junction, autonomic cholinergic synapses, and the brain.
At the neuromuscular junction, these agents work by inhibiting the breakdown of acetylcholine, allowing it to remain bound to the receptor and bind to nearby receptors. This process leads to repetitive firing of the endplate, causing muscle...
At the neuromuscular junction, these agents work by inhibiting the breakdown of acetylcholine, allowing it to remain bound to the receptor and bind to nearby receptors. This process leads to repetitive firing of the endplate, causing muscle...
830
